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ARTICLE
T4SS-dependent TLR5 activation by Helicobacter
pylori infection
Suneesh Kumar Pachathundikandi1,8, Nicole Tegtmeyer1,8, Isabelle Catherine Arnold2, Judith Lind1,
Matthias Neddermann1, Christina Falkeis-Veits3, Sujay Chattopadhyay4, Mark Brönstrup 5, Werner Tegge5,
Minsun Hong6, Heinrich Sticht7, Michael Vieth3, Anne Müller2 & Steffen Backert1*
Toll-like receptor TLR5 recognizes a conserved domain, termed D1, that is present in ﬂagellins
of several pathogenic bacteria but not in Helicobacter pylori. Highly virulent H. pylori strains
possess a type IV secretion system (T4SS) for delivery of virulence factors into gastric
epithelial cells. Here, we show that one of the H. pylori T4SS components, protein CagL, can
act as a ﬂagellin-independent TLR5 activator. CagL contains a D1-like motif that mediates
adherence to TLR5+ epithelial cells, TLR5 activation, and downstream signaling in vitro. TLR5
expression is associated with H. pylori infection and gastric lesions in human biopsies. Using
Tlr5-knockout and wild-type mice, we show that TLR5 is important for efﬁcient control of
H. pylori infection. Our results indicate that CagL, by activating TLR5, may modulate immune
responses to H. pylori.
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H elicobacter pylori is a paradigm persistent pathogencolonizing about 50% of the human world populationand represents a major risk factor for chronic gastritis,
peptic ulceration and gastric malignancies, but host factors con-
trolling the infection and disease development remain obscure1,2.
Toll-like receptors (TLRs) are innate immune receptors for the
detection of invading microbes3–5. TLR5 speciﬁcally detects a
conserved motif present in bacterial ﬂagellins, termed αD1a,
that is expressed by Salmonella, Vibrio and other human-
pathogenic species. In contrast, H. pylori has evolutionarily
acquired speciﬁc mutations in the D1 interaction domain of its
ﬂagellin FlaA to evade immune detection by TLR5 without
compromising ﬂagellar motility6,7. Highly virulent H. pylori
strains harbor the cytotoxin-associated gene pathogenicity
island (cagPAI), which encodes a type IV secretion system
(T4SS), forming a syringe-like pilus structure for translocation
of virulence factors such as CagA and LPS metabolites into
gastric epithelial cells8–10. The T4SS pilus-exposed protein CagL
is required to establish host cell contact and drives effector
delivery11. A role of TLR5 during infection with H. pylori has
been repeatedly excluded due to the low intrinsic activity of its
ﬂagellin6,7,12–14. However, we have reported previously that H.
pylori infection upregulates the expression of TLR5 both on
epithelial and immune cells15. This raised the question which
bacterial factor activates TLR5.
The T4SS delivers multiple factors to the host cytoplasm, which
ensues different cellular signaling for disease formation and
progression8–10. Here we show that the T4SS pilus tip protein
CagL is necessary for NF-κB activation in a TLR5-dependent
manner. CagL sequences from various H. pylori strains around
the globe harbor a D1-like motif, which we show is required for
TLR5 signaling and NF-κB activation. In addition, assays using
human gastric biopsies and mouse models indicate that TLR5
activation and signaling may be important for H. pylori infection
and the associated immune responses.
Results and Discussion
H. pylori activates NF-κB in CagL-dependent TLR5 signaling.
To examine which bacterial factor in H. pylori activates TLR5, we
utilized established HEK293 reporter cells stably transfected with
TLR5 (TLR5+) and additionally expressing a luciferase reporter
for the pro-inﬂammatory transcription factor NF-κB7,12–15. This
system has also the advantage that CagA and LPS metabolites
cannot be translocated into HEK293 cells15,16. Thus, monitoring
of TLR5 activation in these cells is ideally not affected by other
T4SS functions. TLR5 activation was continuously increasing
over 8 h and depended on the multiplicity of infection (Supple-
mentary Fig. 1). Whereas highly virulent cagPAI-positive clinical
isolates speciﬁcally activated NF-κB in TLR5+ cells compared to
the parental controls, isolates lacking the cagPAI showed only
background NF-κB activation (Fig. 1a, b). Any delay in TLR5
activation upon infection with various strains was not seen. These
ﬁndings suggest that the T4SS is required for TLR5 activation.
Next, we infected TLR5+ and parental cells with wild-type (WT)
H. pylori and isogenic mutants of well-known virulence genes.
Whereas the inactivation of vacA, ureB, ﬂaA and cagA did not
abolish TLR5 activation, the loss of cagL and of various structural
T4SS genes abrogated TLR5 activation (Fig. 1c, d and Supple-
mentary Figs. 2 and 3). Remarkably, activation of TLR5 by the
cagPAI was as strong as its activation by recombinant Salmonella
ﬂagellin (rFliC) (Fig. 1d, Supplementary Fig. 4). As another
control, infection of HEK293-TLR4+ reporter cells revealed
T4SS-independent NF-κB activation and no activation by FliC
(Supplementary Fig. 5). To identify the bacterial binding partner
of TLR5, cells were infected or treated with rFliC and subjected to
immunoprecipitation using TLR5-speciﬁc antibodies. Equal
amounts of TLR5 were precipitated (Fig. 1e). Re-probing of the
blot revealed a robust signal for CagL, but not other cagPAI
proteins (Fig. 1e). As expected, rFliC was also co-precipitated,
while FlaAHp did not (Fig. 1e). This suggests that CagL physically
interacts with TLR5 on intact infected epithelial cells.
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Fig. 1 Activation of TLR5 by cagPAI-positive, but not cagPAI-negative H. pylori strains. a H. pylori type-I, but not type-II strains, express a functional
T4SS allowing for CagA phosphorylation in infected AGS cells as control. b TLR5 activation as quantiﬁed by NF-κB luciferase reporter gene assay is
restricted to type-I isolates in HEK reporter cells. c CagA delivery and its phosphorylation in AGS cells require functional cagL and cagA, but not vacA, ureB
and ﬂaA genes. d TLR5 activation in HEK293 cells requires functional cagL. Recombinant ﬂagellin (rFliC) of Salmonella was used as positive control. e, CagL
and rFliC interact with TLR5 on TLR5+ cells as determined by immunoprecipitation with α-TLR5 antibodies. Quantitative data are shown as means ± SD.
****p < 0.0001 (one-way ANOVA). Each red dot represents a single data point. Source data are provided as a Source Data ﬁle.
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Identiﬁcation of TLR5 binding D1-motif in H. pylori CagL. We
next monitored the interaction of ﬂuorescence-labeled bacteria
with TLR5 using live cell imaging17. Infection of parental cells
revealed low ﬂuorescence signals and low binding afﬁnity of both
WT H. pylori and ΔcagL mutant. In contrast, WT but not ΔcagL
mutant bacteria attached ﬁrmly to TLR5+ cells (Fig. 2a). These
data demonstrate that expression of TLR5 permits efﬁcient
attachment of H. pylori to TLR5+ cells, with CagL serving as the
TLR5 ligand on the bacterial surface. This was conﬁrmed by cell
binding assays18 in a time course, showing that TLR5 expression
was required for potent attachment of WT compared to ΔcagL
mutant (Supplementary Fig. 6). To investigate which CagL-motifs
interact with TLR5, we performed peptide arrays19. To this end,
overlapping 15-mer peptides covering the CagL sequence were
spotted on a membrane and probed with recombinant TLR5
(rTLR5) (Supplementary Figs. 7 and 8). Interestingly, rTLR5
bound strongly to the array peptide no. 20 (Fig. 2b). A database
search of the peptide’s sequence (DLALLKANFEANELF)
revealed a remarkable conservation across CagL from isolates
collected in various geographical areas of the world (Supple-
mentary Fig. 9) and high similarity to αD1a domains of TLR5-
activating ﬂagellins from Vibrio, Edwardsiella, Serratia and Sal-
monella species (in particular an 8-residue “DLALLKAN”
sequence, representing a TLR5-activating motif). In contrast, this
motif is absent from FlaAHp and other TLR5-non-activating ﬂa-
gellins of Campylobacter jejuni and Bartonella bacilliformis
(Fig. 2c). Structural inspection of a complex crystal structure
between Salmonella FliC and TLR5 indicates that the respective
ﬂagellin sequence stretch directly interacts with TLR5 (Supple-
mentary Fig. 10a, b). As noted previously13, this stretch contains
one leucine residue, which is highly conserved in various TLR5-
activating ﬂagellins and in CagL (L79), but is absent in the non-
activating ﬂagellins (Fig. 2c). This leucine forms hydrophobic
interactions with F278 of TLR5 (Supplementary Fig. 10c),
whereas the presence of a lysine (K95), as observed in FlaAHp,
would place a positive charge in the proximity of the hydrophobic
F278 sidechain (Supplementary Fig. 10d), thus resulting in an
unfavorable interaction and abrogated TLR5 activation. These
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Fig. 2 The T4SS-pilus protein CagL of H. pylori interacts directly with TLR5. a Binding of FITC-labeled H. pylori G27 WT or ΔcagL mutant to parental and
TLR5+ cells, as monitored over time using the LigandTracer system under live cell conditions. b Peptide arrays of overlapping CagL 15-mer peptides were
incubated with recombinant His-tagged TLR5. Probing with α-His antibodies revealed binding of TLR5 to peptide-20, but not the partially overlapping
peptides-19 or −21. c The peptide-20 sequence of CagL shows homology to the ﬂagellin αD1a domains of TLR5-activating, but not TLR5-non-activating
ﬂagellins. Quantitative data are shown as means ± SD. **p < 0.01; ***p < 0.001 (two-way ANOVA). Source data are provided as a Source Data ﬁle.
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results suggest that H. pylori avoids detection of its FlaA by TLR5,
but instead expresses the T4SS protein CagL to promote binding
and activation of TLR5.
FlaAHp swapped with CagL D1-motif regained TLR5 activa-
tion. To verify these ﬁndings and conﬁrm a key role of CagL in
TLR5 recognition, we swapped the proposed TLR5-activating
motif (DLALLKAN) in CagL with the corresponding sequence of
FlaAHp (VKATQAAQ, a non-TLR5-activating motif) (Fig. 3a) in
the cagPAI-positive strain P12 or cagPAI-negative strain 1061,
respectively. Infection of HEK293 cells showed that com-
plementation of ΔcagL mutant with WT CagL restored TLR5
activation, whereas this was not the case by CagL with deletion of
the DLALLKAN-motif or CagL in which the original sequence
has been replaced by the FlaAHp sequence VKATQAAQ (Fig. 3b).
Genetic complementation of WT FlaAHp did not activate TLR5 as
expected, but introduction of the DLALLKAN sequence of CagL
in FlaAHp restored its potential to activate TLR5 (Fig. 3b). In
addition, we generated point mutations in the evolutionarily
conserved residues of the CagL DLALLKAN-motif including
L79A, L81A or N85A (Supplementary Fig. 11). These proteins
were subjected to binding assays using Dotblots. The results show
that WT CagL and rFliC as well as the corresponding D1-motif
containing FliC peptide (ELAVQSANSTNSQSD) bound rTLR5
with high efﬁciency (Fig. 3c). Single L79 mutation in CagL had
the strongest effect on rTLR5 binding, while L81A or N85A
revealed intermediate levels, which were abolished in the L81A/
N85A double mutant (Fig. 3c). These binding properties corre-
lated perfectly with their capabilities to activate NF-κB in TLR5+
cells in a dose-dependent manner (Fig. 3d) using rFliC as control
(Supplementary Fig. 12). Together, these results suggest that CagL
mimics the TLR5 activation motif of ﬂagellins. This assumption is
further supported by competitive inhibition of rFliC to CagL-
TLR5 binding, showing that CagL and FliC compete for the same
binding site in TLR5 (Supplementary Fig. 13). Interestingly, TLR5
activation by Salmonella FliC involves besides D1 another
domain, called D0 (ref. 12), however, such a domain is absent in
CagL. Thus, CagL represents a unique TLR5-activator protein.
TLR5-dependent responses in H. pylori-infected humans and
mice. We next examined immunohistochemically if the above
ﬁndings are of in vivo relevance in patients. Remarkably, while
antrum biopsies from healthy non-infected individuals showed
no TLR5 staining (Fig. 4a), TLR5 signals appeared upon infection
and gradually increased with the grade of H. pylori colonization
and severity of inﬂammation in the gastric mucosa as classiﬁed by
the updated Sydney System20 (Fig. 4b, c). TLR5+ signals were
mainly detected in epithelial cells, plasma cells and granulocytes
within the lamina propria, while goblet cells were not stained
(Supplementary Fig. 14). Conversely, treatment of H. pylori with
antibiotics downregulated TLR5 expression in the gastric mucosa
to levels detected in uninfected individuals, as assessed at
6–8 weeks after successful eradication (Fig. 4d). Immunoreactive
scoring21 conﬁrmed that TLR5 is signiﬁcantly induced by infec-
tion and coincides with inﬂammation in patients (Fig. 4e). We
next sought to examine the functional contribution of TLR5 to H.
pylori-speciﬁc immunity in mice. To this end, we infected BL6
mice proﬁcient or deﬁcient for tlr5 with strain PMSS1 for three
months and analyzed bacterial colonization levels, gastric
mucosal leukocyte inﬁltration and pathology, and gastric and
lymph node T-cell responses at the study endpoint. Tlr5−/−
animals exhibited a clear defect in controlling the infection
(Fig. 4f), which was associated with strongly reduced Th1
responses in the gastric mucosa (Fig. 4g; Supplementary Fig. 15b).
Interestingly, the gastric frequencies of T cells and neutrophils, as
well as of Th17 and mixed Th1/Th17 T-cell responses were
normal or enhanced in these animals (Fig. 4h-j; Supplementary
Fig. 15a, b), as were Th1 and Th17 frequencies in the mesenteric
lymph nodes (Fig. 4k, l; Supplementary Fig. 15b). The overall
inﬂammation and gastric pathology, as scored by the updated
Sydney system20, was similar and slightly reduced, respectively, in
tlr5−/− relative to WT animals (Fig. 4m, n). No differences in T-
cell or neutrophil frequencies (Fig. 4i, j; Supplementary Figs. 15a,
16a, b), or in gastric histopathology (data not shown) were
observed in naive tlr5−/− relative to WT animals. Interestingly,
chronic infection of WT mice with a PMSS1ΔcagL mutant phe-
nocopied the effects of TLR5 deﬁciency with respect to gastric
Th1 responses (Fig. 4o, p, Supplementary Fig. 15b). The coloni-
zation of this mutant was slightly, but not signiﬁcantly, reduced
(Supplementary Fig. 16c). The combined results suggest that the
detection of CagL-positive H. pylori by TLR5 is an important
element in the generation or maintenance of a local adaptive
immune response to this infection, and loss of TLR5 results in
hyper-colonization. TLR5 deﬁciency thus phenocopies the effects
of genetic inactivation of the entire T4SS.
CagL acts as TLR5 agonist for cytokine responses. Finally, we
aimed to investigate the role of TLR5 signaling in initiating innate
and adaptive immune responses. Gene expression proﬁling of
TLR5+ and parental cells exposed to H. pylori or not was con-
ducted by microarrays and revealed the signiﬁcant up-regulation
of tumor necrosis factor (TNF) and NF-κB-dependent chemokine
responses in TLR5+ compared to the parental cells (Supple-
mentary Figs. 17 and 18; Supplementary Tables 1 and 2). In
particular, several chemokines and cytokines (CCL2, CCL20,
CXCL1, CXCL10, IL-32, IL-17F and others) were differentially
expressed upon infection. Interestingly, CCL20 was reported
previously to be speciﬁcally induced by Salmonella ﬂagellin, but
not by LPS or intestinal microbiota, for recruitment of immature
dendritic cells, which then triggered innate and adaptive immu-
nity22,23. We conﬁrmed by ELISA that CCL20 expression was
also stimulated in a TLR5-dependent manner in HEK293
reporter cells and cultured T84 cells expressing endogenous TLR5
by co-incubation with rCagL or rFliC, and infection with WT
H. pylori, but not ΔcagL mutant (Supplementary Fig. 19). In
addition, CXCL10 was differentially expressed by infected TLR5+
cells in our microarrays.
Recently, a protective mucosal role of ﬂagellin was reported
and that ﬂagellin induced CXCL10, and recombinant CXCL10
protected mice from Candida albicans infection24. Moreover,
CXCL10 expression was also induced by engineered anti-tumor
T cells expressing ﬂagellin25. Furthermore, CCL2 is induced by H.
pylori in a TLR5-dependent manner. This is particularly
interesting as a functional CCL2/CCR2 axis, driving the
recruitment of monocytes and macrophages into the infected
mucosa, is required for Th1 immunity to H. pylori26. The loss of
CCR2 phenocopies all aspects (hyper-colonization, reduced Th1
responses but normal Th17 responses) of TLR5 deﬁciency,
indicating that one key consequence of TLR5 signaling in gastric
epithelial cells may be the recruitment of these cells and the
subsequent initiation of a protective T-cell response (see model in
Fig. 5a). We propose that H. pylori triggers TLR5 signaling in
order to eliminate bacterial competitors in the gastric niche.
These ﬁndings nicely complement previous work on the role of
TLR2 (refs. 27,28), TLR9 (ref. 29) and TLR10 (refs. 28,30) during H.
pylori infection. The unresponsive ﬂagellin and the shift of
recognition by TLR5 to CagL demonstrated here, suggest a
remarkable co-evolution of these important factors during the
course of H. pylori interaction with the host. We propose that this
shift endows H. pylori with the unique ability to avoid permanent
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TLR5 activation by exposing or hiding CagL, respectively (Fig. 5b,
c), which is in line with earlier observations that pilus function
can turn on and turn off through recombination in T4SS protein-
coding genes8. One consequence of long-term infection with
CagL-positive strains, but not CagL-negative strains, is a greatly
increased likelihood of serious sequelae, particularly peptic ulcer
disease and gastric cancer. According to the background levels
produced by cagL and other cagPAI mutants we also propose that
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there is at least one more H. pylori factor targeting TLR5.
Learning how TLR5 signaling by H. pylori could be responsible
for immune control of the bacteria can teach us as much about
human biology as it does about the pathogenesis of these
important infections.
Methods
H. pylori growth, mutagenesis and infection experiments. The H. pylori strains
employed in this study include the cagPAI-positive wild-type (WT) isolates P1,
P12, 26695, NCTC11637, G27, N6 and PMSS1 as well as the cagPAI-negative WT
isolates 1061, Safr7, Ka125 and UH4 (refs. 11,15–18,22,27,31–33). Isogenic mutant H.
pylori were generated by standard gene disruption by insertion procedures using
kanamycin or chloramphenicol resistance gene cassettes, respectively31–34. Genetic
complementation of cagL and ﬂaA genes was performed in the urease locus on the
chromosome using standard procedure34. All H. pylori strains were grown in thin
layers on horse serum agar plates supplemented with vancomycin (10 μg/mL),
nystatin (1 μg/mL) and trimethoprim (5 μg/mL) and the mutant strains were
selected by adding kanamycin (8 μg/mL) or chloramphenicol (4 μg/mL), respec-
tively. All antibiotics were obtained from Sigma-Aldrich (St. Louis, USA). Incu-
bation of the bacteria was performed at 37 °C for 2 days in an anaerobic jar
containing a Campygen gas mix of 5% O2, 10% CO2 and 85% N2 (Oxoid, Wesel,
Germany). H. pylori grown on agar plates was harvested and resuspended in
Phosphate Buffered Saline (PBS, pH 7.4) using a sterile cotton swab (Carl Roth,
Karlsruhe, Germany). The bacterial concentration was measured as optical density
(OD) at 550 nm using an Eppendorf spectrophotometer. The number of bacteria
was also cross-checked with colony-forming units (CFU) grown on horse serum
agar plates after serial dilution of the bacterial suspension. The eukaryotic cells
grown in medium without antibiotics and antimycotics were infected with H. pylori
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at a multiplicity of infection (MOI) of 5 to 200 for 8 h (Supplementary Fig. 1).
Optimal results were obtained using MOI of 25, which were then applied in all
subsequent studies. The uninfected mock control cells were incubated with equal
amount of PBS.
Protein expression and puriﬁcation of recombinant CagL. Recombinant
CagLWT and mutants were expressed as C-terminal His-tag fusions in vector
pET28a (Novagen, Merck Millipore, Darmstadt, Germany). Site-directed muta-
genesis of CagL was done by PCR using pET28a-CagLWT plasmid as DNA tem-
plate. Ampliﬁcation was performed in 50 μl reactions containing 2 mM MgCl2,
0.2 mM dNTP, 0.2 μM of each primer (Supplementary Table 3) and 0.5 units
Phusion High-Fidelity DNA Polymerase (NEB, Ipswich, USA), followed by PCR
puriﬁcation (NucleoSpin Gel and PCR Clean-up, Macherey-Nagel, Düren, Ger-
many), digestion with DpnI (NEB) and ligation using T4 DNA Ligase (NEB). Re-
sequencing and Western blotting proved the correct expression of CagL in the
resulting plasmids. Puriﬁcation of the CagL variants was performed by using
established methods11 including some improvement steps. Brieﬂy, induction of
expression was carried out at 16 °C for 20 h. CagL was puriﬁed under native
conditions by afﬁnity chromatography through HisTrap HP (GE Healthcare,
Buckinghamshire, UK), a HiTrap Q HP (GE Healthcare) and then gel ﬁltration
through Superdex-75 (GE Healthcare). The apparent size of puriﬁed CagL was
estimated to be 27 kDa. Puriﬁcation of CagL was judged to be of >95% homo-
geneity by SDS-PAGE/Coomassie Blue staining (Supplementary Fig. 11). The
folded conformation of the puriﬁed CagL proteins was conﬁrmed by circular
dichroism using spectropolarimeter. HEK293 parental and TLR5+ cells were
treated with 5 μg/mL of CagL proteins for 12 h. NF-κB activity was monitored by
standard luciferase reporter gene assay.
Protein expression and puriﬁcation of rTLR5 from zebraﬁsh. To date, a fusion
version of TLR5 is the only available soluble recombinant TLR5 (rTLR5) protein to
be an active receptor for ﬂagellin recognition7. For rTLR5, the N-terminal fragment
of zebraﬁsh TLR5 (amino acid residues 22–390) was fused with the C-terminal
fragment of hagﬁsh variable lymphocyte receptor (VLR residues 126–200). In
addition, the rTLR5 is appended to the C-terminal thrombin cleavage site, Strep-
tag II (WSHPQFEK) and His6 tag to facilitate puriﬁcation. rTLR5 was expressed
and puriﬁed by established standard procedure7. rTLR5 was secreted in the Hi5
insect cell expression system after infecting with rTLR5 expression baculovirus.
rTLR5 was puriﬁed using Ni-NTA afﬁnity (Qiagen) and Strep-Tactin afﬁnity
chromatography (IBA Lifesciences). The puriﬁed rTLR5 was dialyzed against in
20 mM HEPES (pH 7.4), 150 mM NaCl and 1.5 mM β-mercaptoethanol and
analyzed by SDS-PAGE.
CagL peptide SPOT arrays. The CagL peptide arrays were generated by the
SPOT-synthesis technique. Brieﬂy, the indicated peptides in Supplementary Fig. 4
were synthesized on an amino-functionalized cellulose membrane using Fmoc/tert-
butyl chemistry. Each spot consists of 5 nmol peptide. For binding assays, the
peptide arrays were blocked overnight at room temperature with 10 mL blocking
buffer consisting of 2 × blocking buffer concentrate (Sigma-Aldrich) and 5% (w/v)
sucrose in TBS-T (0.02 M sodium phosphate buffer with 0.1 M sodium chloride
(pH 7) and 0.05% Tween-20). Five µg/mL recombinant zebraﬁsh TLR protein (His-
tagged) in blocking buffer were added to the peptide arrays and incubated for 4 h at
room temperature while rotating. Afterwards, the arrays were washed three times
with 15 mL of TBS-T buffer and then incubated with 40 μL mouse α-Tetra-His-
antibody (Qiagen, cat. no. 34670) in 8 mL blocking buffer resulting in a 1:200
dilution for 2 h at room temperature . Finally, a secondary horseradish peroxidase
conjugated α-mouse antibody (Life Technology, Darmstadt, Germany, cat. no.
31446) diluted 1:10,000 in 10 mL blocking buffer was used and antibody detection
was performed with the ECL Plus chemiluminescence Western blot kit (GE
Healthcare) as described below. The mock control without peptide on the blots
revealed no signals, as expected (see Fig. 2b, position C20–25).
Protein binding and competition assays. The indicated recombinant CagL
proteins (1 μg each), FliC protein (1 μg) and FliC peptide as control were immo-
bilized on Dotblots, followed by incubation with 1 μg recombinant TLR5 using the
above protocol for peptide SPOT arrays. Site-directed mutagenesis in the D1-motif
of CagL was performed34 to investigate the importance of single amino acids in
TLR5 binding. We also accomplished competition assays by adding growing
amounts of rFliC as indicated in the reactions shown in Supplementary Fig. 12, in
order to investigate if CagL and FliC compete for the same binding site in TLR5.
Bound TLR5 was visualized using α-TLR5 antibodies handled according to our
Western blot protocol (see below) and signal intensities were quantiﬁed
densitometrically.
Eukaryotic cell culture. The human gastric adenocarcinoma cell line AGS (ATCC
CRL-1739) was grown in RPMI-1640 medium, which was supplemented with 10%
fetal calf serum (Gibco, Paisley, UK). The human embryonic kidney cells (HEK293
parental, ATCC CRL-1573) and HEK293 cells stably transfected with the
pUNOhTLR5 (TLR5+) or pUNOhTLR4 (TLR4+) constructs (cat. no. 293-htlr5
and no. 293-htlr4a, InvivoGen, San Diego, USA) and T84 cells (ATCC CCL-248)
were cultured in Dulbecco’s Modiﬁed Eagle Medium (DMEM) containing 4.5 g/L
D-glucose, 4 mM L-glutamine, 110 mg/L sodium pyruvate, 10% FBS (Invitrogen,
Carlsbad, USA) and were supplemented with 1% antibiotic and antimycotic
solution (Sigma-Aldrich) and 10 μg/mL blasticidin (InvivoGen). All cell lines were
cultivated at 37 °C in incubators with 5% (v/v) CO2 and subcultured in a ratio of
1:3 to 1:5 every 2 to 3 days at a conﬂuence of 70 to 90%. Cells were commonly
maintained in 75-cm2 tissue culture ﬂasks and seeded into 6- or 12-well plates
(Greiner-Bio-One, Germany) before infection.
Whole genome microarray hybridization. RNA was isolated using the RNeasy
Mini Kit (Qiagen) according to the manufacturer’s protocol. The quality of RNAs
for microarray analysis was approved by the Agilent 2100 Bioanalyzer platform
(Agilent Technologies, Santa Clara, USA). The best quality RNAs were used for
further steps. One hundred ng of each total RNA sample was used for the linear
T7-based ampliﬁcation and Cy3-labeled cRNA were prepared using the Agilent
Low Input Quick Amp Labeling Kit. Yields of cRNA and the dye-incorporation
rate were measured with the ND-1000 Spectrophotometer (NanoDrop Technolo-
gies, Wilmington, USA). The hybridization of Cy3-labeled cRNA was performed
using the Agilent 60-mer oligo microarray processing protocol using the Agilent
Gene Expression Hybridization Kit. Brieﬂy, 0.6 μg Cy3-labeled fragmented cRNA
in hybridization buffer was hybridized overnight (17 h, 65 °C) to Agilent Whole
Human Genome Oligo Microarrays 8x60K V2 using Agilent’s recommended
hybridization chamber and oven. Subsequently, the microarrays were washed once
with the Agilent Gene Expression Wash Buffer-1 for 1 min at 25 °C followed by a
second wash with preheated Agilent Gene Expression Wash Buffer-2 (37 °C) for
1 min Fluorescence signals of the hybridized Agilent Microarrays were detected
using Agilent’s Microarray Scanner System. The Agilent Feature Extraction Soft-
ware (FES) was used to read out and process the microarray image ﬁles. The above
procedures were performed at the microarray service centre of Miltenyi Biotec
(Bergisch Gladbach, Germany).
Microarray data analysis. Three replicates were analyzed for each of the sample
groups. After background correction of intensity data for all individual micro-
arrays, quantile normalization was conducted between arrays. The normalized
intensities were log2-transformed and served as basis for further analysis. One-way
ANOVA (p ≤ 0.01) was applied among the samples and the differential expression
Fig. 4 TLR5 responses in the gastric mucosa of H. pylori-infected patients and mice. a–d Immunohistochemistry of TLR5 expression in gastric biopsies of
patients. Scale bar: 200 µm. Non-infected antrum mucosa (a) exhibits neither pathological changes nor TLR5-positive cells, whereas antrum mucosa (b)
with moderately chronic, slightly active gastritis and moderate H. pylori colonization shows cytoplasmic and nuclear TLR5 staining of the surface epithelium
and cytosolic staining of plasma cells. c Antrum mucosa with chronic moderately active gastritis in the presence of marked H. pylori colonization with a
basal lymphoid follicle and slight intestinal metaplasia with slight atrophy of glands shows strong cytoplasmic and nuclear TLR5 staining of the epithelium
and cytosolic staining of plasma cells. d Antrum mucosa of a gastritis patient who underwent treatment for bacterial eradication. TLR5-expression was
reduced to non-infected control levels. e ImmunoReactive Score (IRS) quantiﬁcation of TLR5 staining in patients. *p≤ 0.05; ****p < 0.0001 (one-way
ANOVA). f–n tlr5−/− and wild-type (WT) mice were infected with H. pylori for three months (+Hp 3mths). f Bacterial colonization as determined by
plating and colony counting. g frequencies of IFN-γ+, h IL-17+ and of cells expressing both cytokines, among gastric lamina propria CD4+ TCRα/β+ T cells,
as determined by ﬂow cytometry. i, j Frequencies of lamina propria CD4+ T cells and Ly6G+ neutrophils among all CD45+ leukocytes. k, l Frequencies of
IFN- γ + and IL-17+ cells among all MLN CD4+ TCR α/β+ T cells. m, n Gastric inﬂammation and hyperplasia, respectively, as scored on a scale of 0–6
based on the updated Sydney classiﬁcation on two Giemsa-stained sections per mouse. o, p WT mice were infected with H. pylori PMSS1 WT or its CagL-
deﬁcient mutant for three months. Frequencies of IFN-γ+ and IL-17+ cells, among gastric lamina propria CD4+ TCRα/β+ T cells, as determined by ﬂow
cytometry. The nonparametric Mann–Whitney U-test was used for all statistical comparisons (f–p); *p < 0.05; **p < 0.01; ***p < 0.001. Source data are
provided as a Source Data ﬁle.
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analysis between samples was done using two class unpaired Signiﬁcance Analysis
of Microarrays (SAM) method35 with TIGR MeV software version 4.9.0, adjusting
delta parameter to ensure the lowest median number of false signiﬁcant genes
(FDR= 0). The data were evaluated using Tukey’s post-hoc test (ANOVA) and
Benjamini & Hochberg method (FDR). The derived signiﬁcant differential gene
expression data were used for plotting hierarchical clustering by the method of
Euclidean distance, complete linkage. The microarray dataset is available at GEO
database through accession number GSE123623.
Functional classiﬁcation of differentially expressed genes. DAVID (Database
for Annotation, Visualization and Integrated Discovery) v6.8 tool was used to
identify the differential expressed genes related to biological pathway or process by
selecting Genetic Ontology term GOTERM_BP_FAT and KEGG pathway for
functional clustering. The signiﬁcant highly enriched (Highest stringency, EASE
Score >2.0, p < 0.001) clusters among genes differentially expressed in H. pylori-
infected TLR5+ (2/31 clusters) and parental cells (4/11 clusters), respectively, were
identiﬁed.
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Transfection of HEK293 cells and NF-κB luciferase assay. HEK293 parental,
TLR5+ and TLR4+ cells (2 × 105/mL each) were cultured in 12-well plates and
transfected with 2 µg of the NF-κB luciferase construct15 for 48 h with TurboFect
reagent according to the manufacturer’s instructions (Thermo Fisher Scientiﬁc,
Waltham, USA). Transfected cells were infected with H. pylori for 8 h at MOI= 25
or treated with rFliC (100 ng/mL) and analyzed by luciferase assay. Brieﬂy, cells
were harvested by passive lysis in lysis buffer (25 mM HEPES, 2 mM EDTA,
20 mM DTT, 5% Glycerol, 1% Triton X-100, pH 7.8). A portion of the lysate was
used to measure relative light units (luciferase activity) using the Luciferase Assay
buffer (25 mM HEPES, 15 mMMgSO4, 5 mM ATP, 0.5 mM D-Luciferin, pH 7.8) in
Orion Microplate Luminometer (Titertek Berthold, Pforzheim, Germany). The
protein concentration of each lysate was measured with Bradford protein assay
reagent (Bradford, Hercules, USA) and equal amount of lysis buffer was used as
blank. The relative light units were normalized with protein concentration and the
values were plotted as ratio of test versus control samples.
Enzyme-linked immunosorbent assay. Human T84 cells were reported pre-
viously to express endogenous TLR5 that is responsive to Salmonella FliC22. Thus,
we infected T84 cells with H. pylori or treated them with recombinant proteins as
described above. After 24 h, supernatants were collected and subjected to cytokine
ELISA. CCL20 concentrations in the culture medium were determined using the
Quantikine ELISA kit and protocol provided by the manufacturer (R&D Systems,
USA). Treatment of the cells with 10 ng/mL recombinant TNF served as control
(R&D Systems)36.
Inhibition of TLRs by neutralizing antibodies. To further determine the identity
of the TLR5 ligand on the HEK293 cells, the cells were investigated in the presence
or absence of the α-hTLR5 neutralizing antibody. HEK293 parental and TLR5+
cells (2 × 105 per mL of culture) were incubated with α-human TLR5 (α-hTLR5)
IgA, which is a neutralizing monoclonal antibody (mAB) to human TLR5, that
blocks ﬂagellin-induced cellular activation (InvivoGen, cat. no. maba2-htlr5). The
neutralizing ability of α-hTLR5-IgA antibodies was accessed at various con-
centrations ranging from 10 ng/mL to 1 μg/mL as described by the manufacturer.
Incubation was allowed for 1 h, followed by treatment with rFliC or H. pylori
infection as described above. Inhibition of TLR4 in expressing HEK293 cells was
performed with a neutralizing monoclonal antibody (mAB) to human TLR4 using
a similar protocol (InvivoGen, cat. no. mabg-htlr4). As a positive control for TLR4
activation in HEK293 cells, we applied Escherichia coli LPS (Sigma-Aldrich) and
polymyxin B as inhibitor using standard protocols (InvivoGen).
FlaA and CagL sequence analysis. All protein sequences were obtained from the
NCBI GenBank database. Multiple protein sequence alignments, such as in Fig. 2c
and Supplementary Fig. 9, were performed by applying Clustal Omega program
(version 1.2.4), that uses seeded guide trees and HMM proﬁle-proﬁle techniques to
generate alignments between three or more sequences (https://www.ebi.ac.uk/
Tools/msa/clustalo/). Sequences were assembled manually and aligned by Clustal
Omega using the default parameters. Accession numbers for the sequences used
in Fig. 2c are as follows Helicobacter pylori CagL (NP_207335.1), Vibrio angu-
illarum FlaA (CDQ50898.1), Edwardsiella tarda FliC (AAN52540.1), Serratia
marcescens FliC (BAO34403.1), Salmonella enterica FliC (ATI85802.1), Helico-
bacter pylori FlaA (AAD07667.1), Campylobacter jejuni FlaA (CAL35451.1) and
Bartonella bacilliformis FlaA (ABM44761.1).
3D modeling. The structure of H. pylori FlaAHp in complex with zebraﬁsh TLR5
(zTLR5) was modeled using the complex of Salmonella ﬂagellin with zebraﬁsh
TLR5 (PDB: 3V47as template)7. Modeling was performed with Modeller 9.1637.
Structure analysis and visualization were done using Swiss-Model38 and RasMol39.
Histology. Biopsies from patients in four groups (non-infected controls n= 11,
medium grade infection n= 9, high grade infection n= 10, H. pylori eradicated by
conventional triple therapy n= 6) were ﬁxed in 4% neutral buffered formalin and
parafﬁnized in an increasing series of alcohol and xylene. After manual orientation
of the biopsies to allow perpendicular cuts the parafﬁn blocks were cut into 4
micron thick slides and stained with hematoxylin and eosin. For detection of
H. pylori a Warthin-Starry Sliver stain was performed. All analyses with human
biopsies were reviewed and approved by the FAU Ethics Commission Ofﬁce in
Erlangen/Germany (license 344_16 BC to S.B.).
Immunohistochemistry. α-TLR5 antibodies (Thermo Fisher Scientiﬁc, cat. no.
36–3900) were used to stain speciﬁcally cytoplasmatic epithelial and inﬂammatory
cells. For retrieval of antigens, deparafﬁnised sections were heated in citrate buffer
(pH 6.0) using a microwave for 20 min Also, endogenous peroxidase was blocked
by 20 min incubation with 0.3% hydrogen peroxidase in absolute methanol. Sec-
tions were rinsed by washing buffer and nonspeciﬁc binding was blocked by the use
of normal serum (Nichirei, Tokyo, Japan). Overnight incubation at 4 °C was car-
ried out for binding of the α-TLR5 primary antibody. Afterwards, 30 min incu-
bation with biotinylated secondary antibody was performed, followed by substrate
binding by using streptavidin–biotin–peroxidase method. Counterstaining with
haemalaun was done additionally in all cases. For all stains, renal positive controls
were performed, and staining was only accepted if evaluable results of controls
showed the expected results. If not, staining was repeated until internal controls
showed appropriate results. Scoring of positivity was performed blinded by two
pathologists according to the ImmunoReactive Score (IRS) system21. The per-
centage of positive cells was divided into ﬁve grades: 0–4 (0%, <10%, 10–50%,
51–80%, >80%) multiplied with the grade of intensity (graded from 0 to 3) of the
immunohistochemical reaction. Pictures in Fig. 4a–d are shown at 40×
magniﬁcation.
H. pylori infection of mice. C57BL/6 WT and tlr5−/− mice (backcrossed for >10
generations to C57BL/6 background by the vendor) were obtained from the
Jackson Laboratory (Bar Harbor, USA). Animals were bred and maintained under
speciﬁc pathogen-free conditions in accredited animal facilities at the University of
Zürich. All animal experimentation was reviewed and approved by the Zürich
Cantonal Veterinary Ofﬁce (licence ZH24/2013 to A.M.). Mice were infected orally
on two consecutive days with 108 CFU of H. pylori PMSS1 at 6 weeks of age and
analyzed at 3 months p.i. Uninfected mice served as controls. Infected WT and
tlr5−/− females were co-housed to minimize possible confounding effects of
putative differences in the microbiota of these animals; unfortunately, this was not
possible with males. Data in Fig. 4f are pooled from three independent studies, and
data in Fig. 4g–j are pooled from 2 of these 3 studies. Data in Fig. 4k, l is from one
large independently conducted study. Separate analysis of the co-housed females
only (of which 9 were wild type and 5 were tlr5−/−) conﬁrmed all trends observed
with the entire (mixed) cohort, but some comparisons (histology, Th1 inﬁltration)
did not reach statistical signiﬁcance due to smaller sample sizes. The difference in
colonization levels of co-housed WT and tlr5−/− females was statistically sig-
niﬁcant. The H. pylori strain used in this study, PMSS1, is a clinical isolate of a
patient with duodenal ulcer and the parental strain of the mouse-derivative Sydney
strain 1 (SS1)22. H. pylori was grown on horse blood agar plates and in liquid
culture in an anaerobic jar under microaerophilic conditions as described above27.
Cultures were routinely assessed by phase contrast microscopy for contamination,
morphology and motility. For gastric histopathological analysis of mouse tissue,
stomach sections were ﬁxed in 10% neutral-buffered formalin prior to parafﬁn
embedding and Giemsa staining. Two longitudinal sections per mouse spanning
the length of the stomach from the forestomach/corpus junction to the antrum/
duodenum junction were scored with regard to four histopathological parameters
(chronic inﬂammation, gastric atrophy, intestinal metaplasia, mucus pit cell/epi-
thelial hyperplasia), based on the features described in the updated Sydney
Fig. 5 Models for TLR5-mediated and CagL-dependent H. pylori pathogenesis. a TLR5 is not expressed in healthy gastric tissue. H. pylori infection induced
the expression of TLR5 in infected gastric patients and TLR5 disappeared after eradication suggesting a tight regulation of this receptor. These data are in
agreement with infection studies in WT and TLR5−/− mice, which document that TLR5 controls immune responses and colonization by H. pylori. TLR5
recognition of H. pylori occurs through the T4SS pilus protein CagL having a D1 mimetic motif, while recognition of ﬂagellin is avoided. In addition, CagL-
mediated TLR5 activation up-regulated the expression of several chemokines and cytokines, as well as its receptors. Various immune cell attracting
chemokines such as CXCL1, CXCL3, CCL2, CXCL10, CCL20 and cytokines TNF, IL-32 and IL-17F were increased both by TLR5-dependent and -independent
signaling pathways as indicated. Moreover, the combined expression of CCL20, TNF and TNF receptor (TNFR) imply the induction of mucosal lymphoid
tissue formation through TLR5-dependent signaling. Infected gastric biopsies from patients exhibit an increased expression of TLR5 on plasma cells in the
gastric mucosa. This raises the possibility of CagL-TLR5 dependent IgA production in mucosal lymphoid tissues and secretion into the gastric lumen to
control the H. pylori infection. The various signaling-engaged protein classes are highlighted with different colors as outlined at the bottom. b H. pylori
expresses an unresponsive ﬂagellin (“OFF” status) and instead expresses the T4SS-pilus surface protein CagL, which can trigger TLR5 activation when
T4SS pili are expressed (“ON” status). c However, T4SS pilus functions can be turned on and off through recombination in T4SS proteins8. This shift
provides H. pylori with the unique ability to avoid permanent TLR5 activation by hiding CagL in the T4SS “OFF” status. We propose that, by engaging TLR5,
H. pylori may be able to control the host inﬂammatory response and its own colonization.
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classiﬁcation20. Speciﬁcally, the deﬁnition of scores was as follows for chronic
inﬂammation: 0, none; 1, some inﬁltrates; 2, mild (few aggregates in submucosa
and mucosa); 3, moderate (several aggregates in submucosa and mucosa); 4,
marked (many big aggregates in submucosa and mucosa); 5, nearly the entire
mucosa contains a dense inﬁltrate; 6, entire mucosa contains a dense inﬁltrate and
hyperplasia: 0, none; 1, single glands (next to inﬁltrate); 2, one focal area /1–4
crypts (mild); 3; 1–3 foci; 4, multiple foci; 5, > 50% of glands affected; 6, only few
small non-hyperplasic areas. Statistical analysis on all mouse work was performed
with Prism 6.0 (GraphPad Software). The nonparametric Mann–Whitney U-test
was used for all statistical comparisons. Differences were considered statistically
signiﬁcant when p < 0.05. *p < 0.05, **p < 0.01 and ***p < 0.001.
Leukocyte isolation from mice. For lamina propria (LP) leukocyte isolation,
gastrointestinal tissues were opened longitudinally, washed and cut into pieces.
Pieces were incubated in Hanks' balanced salt solution with 10% FCS and 5 mM
EDTA at 37 °C to remove epithelial cells. Tissue was digested at 37 °C for 50 min in
a shaking incubator with 15 mM HEPES, 500 U/mL of type IV collagenase (Sigma-
Aldrich) and 0.05 mg/mL DNase I in RPMI-1640 medium supplemented with 10%
fetal bovine serum and 100 U/mL penicillin/streptomycin. Cells were then layered
onto a 40/80% Percoll gradient, centrifuged and surface of the cell layer was gently
washed in PBS with 0.5% BSA. MLN cell suspensions were prepared by digesting
the tissue with 500 U/mL of type IV collagenase in RPMI-1640 medium for 15 min
followed by pushing through a cell strainer using a syringe plunger.
Flow cytometry. For surface staining, cells were stained in PBS with 0.5% bovine
serum albumin with a ﬁxable viability dye and a combination of the following
antibodies: anti-mouse CD45 (30-F11), Ly6G (1A8), CD4 (RM4–5) and TCRβ
(H57–597) (all from BioLegend, San Diego, USA, Supplementary Table 4). Fc block
(anti-CD16/CD32, Affymetrix, Santa Clara, USA) was included to minimize
nonspeciﬁc antibody binding. For intracellular cytokine staining of T cells, cells
were incubated for 3.5 h in complete IMDM medium containing 0.1 μM phorbol
12-myristate 13-acetate and 1 μM ionomycin with 1:1,000 Brefeldin A (eBioscience,
Vienna, Austria) and GolgiStop solutions (BD Biosciences, Franklin Lakes, USA) at
37 °C in a humidiﬁed incubator with 5% CO2. Following surface staining, cells were
ﬁxed and permeabilized with the Cytoﬁx/Cytoperm Fixation/Permeabilization
Solution Kit (BD Biosciences) according to the manufacturer's instructions. Cells
were stained for 50 min with antibodies to IL-17A (TC11–18H10.1) and IFNγ
(XMG1.2, Biolegend, Supplementary Table 4). Total leukocyte counts were
determined by adding countBright Absolute Counting Beads (Life Technologies) to
each sample prior to analysis. Samples were analyzed on a LSRII Fortessa (BD
Biosciences) or sorted on a FACSAriaIII (BD Biosciences) to a purity of >95%.
Analysis was performed using FlowJo software (Tree Star, Ashland, USA).
Immunoprecipitation. 1 × 107 of HEK293 TLR5+ cells (mock control, infected
with H. pylori or treated with rFliC) were washed with cold PBS and lysed for
30 min at 4 °C in lysis buffer (20 mmol/L Tris pH 7.2, 150 mmol/L NaCl, 5 mmol/L
ethylenediaminetetraacetic acid, 1% Triton X-100, 10% glycerol, 1 mmol/L
Na3VO4, COMPLETE) as in the established standard protocol33. Lysates were
precleared with protein G-Sepharose (GE Healthcare) for 2 h at 4 °C. Polyclonal α-
TLR5 (2 μg per sample, Supplementary Table 4) was added to the supernatants and
incubated overnight at 4 °C. Immune complexes were precipitated by the addition
of protein G-Sepharose for 2 h and washed once with lysis buffer and three times
with 0.5× PBS. Afterwards, the samples were subjected to SDS-PAGE and Western
blotting as described below.
SDS-PAGE and immunoblot analysis. Infected and control cells were harvested
and mixed with equal amounts of 2× SDS-PAGE buffer and boiled for 5 min
Proteins were separated by SDS-PAGE on 6–12% polyacrylamide gels and blotted
onto PVDF membranes (Immobilon-P, Merck Millipore, Darmstadt, Germany).
Before addition of the antibodies, membranes were blocked in TBS-T (140 mM
NaCl, 25 mM Tris-HCl pH 7.4, 0.1% Tween-20) with 3% BSA or 5% skim milk for
1 h at room temperature. Phosphorylated and non-phosphorylated CagA proteins
were detected by incubation of the membranes with a mouse monoclonal α-
phosphotyrosine antibody PY99 diluted 1:1,000 (Santa Cruz, USA, cat. no. sc-7020)
and a rabbit polyclonal α-CagA antibody diluted 1:2,000 (Austral Biologicals, San
Ramon, USA, cat. no. HPP-5003–9), respectively. The rabbit polyclonal α-Flagellin
antibody was reported previously40. Rabbit polyclonal α-CagL, α-CagM, α-CagN,
α-Cag3 and human GAPDH antibodies were generated by immunizing rabbits
against protein-derived peptides (Supplementary Table 4)11. Immunization was
carried out in accordance with German Tierschutzgesetz and Tierschutz-
Versuchsverordnung as implementation of the EU directive 2010/63/EU. The
protocol was registered and approved by Landesamt für Landwirtschaft, Lebens-
mittelsicherheit und Fischerei Mecklenburg-Vorpommern (LALLF M-V, Rostock,
Germany). All antibodies were afﬁnity-puriﬁed and prepared according to standard
protocols by Biogenes GmbH (Berlin, Germany). Polyclonal antibodies recognizing
TLR5 were purchased from Santa Cruz (USA). As secondary antibodies, horse-
radish peroxidase-conjugated α-mouse or α-rabbit polyvalent goat immunoglo-
bulins, respectively, were used (Thermo Fisher Scientiﬁc, Massachusetts, USA).
Antibody detection was performed with the ECL Plus chemiluminescence Western
Blot system for immunostaining (GE Healthcare). Uncropped and unprocessed
western blot scans are supplied in the Source Data ﬁle.
Fluorescence labeling of H. pylori. H. pylori G27 WT and its isogenic ΔcagL
mutant were cultivated on horse serum GC agar plates as described above. For
labeling, the bacteria were harvested and resuspended in phosphate buffered saline
(PBS, pH 7.4). The labeling of the bacteria with Fluorescein isothiocyanate (FITC)
(Sigma-Aldrich) was performed as in standard protocol17. After the labeling pro-
cess, the bacteria were stored at −80 °C in BHI medium (Oxoid) with 20% glycerol
(Carl Roth, Karlsruhe, Germany) until use.
Real-time adhesion of H. pylori by the LigandTracer Green System. The
LigandTracer Green instrument (Ridgeview Instruments AB, Uppsala/Sweden) was
used to quantify the interaction of H. pylori to HEK293 TLR5+ and parental cells
in real time and under live cell conditions. In order to maintain experimental
conditions at 37 °C and 5% CO2, the LigandTracer was placed in a Hera Cell 150i
CO2 incubator (Thermo Fisher). Twenty-four hours before the experiments, 2 x
106 of freshly split HEK293 cells were seeded in a Poly-L-lysine (Sigma-Aldrich)
coated Nunclone Surface petridishes (Nunc A/S, Roskilde, Denmark) according to
the manufacture’s protocol provided by Ridgeview. The conﬂuence of each cell
monolayer was about 90% as conﬁrmed by light microscopy. These plates contain a
cell-free area, which was used as the background reference. Before the measure-
ment, the growth media was discarded and the cells were washed three times with
fresh DMEM and 10% FCS. Three mL of the same media were added and the plate
was placed into the LigandTracer Green apparatus. For the experiment, the
“general assay” template was used as provided by the LigandTracer Control soft-
ware. After a 30 min background measurement, 100 μL of FITC-labeled H. pylori
G27 WT or G27ΔcagL of OD600= 1.0 were added to the cells. The ﬂuorescence
intensity of bacterial cells binding to the HEK293 cells was measured in the rotating
dish over a time course of 90 min, registered once every 60 s by the ﬂuorescence
detector and compared to the reference signal of the opposite cell-free part of
the dish.
Cell binding assay. Infection of parental and TLR5+ cells at about 80% conﬂuency
was performed at a density of about 3.5 × 105 cells in six‐well plates as reported
earlier18. Following infection with H. pylori in a time course of 2, 4 and 8 h, the
cells were washed three times with 2 mL of pre-warmed culture medium without
antibiotics to eliminate non-attached H. pylori. For counting of cell‐bound bacteria
as total colony-forming units (CFU), the cells were incubated for 15 min at 37 °C
with 1 mL of PBS buffer and 0.1% saponin. Afterwards, the cell suspensions were
collected and serial dilutions incubated on GC agar plates. The number of CFUs
was determined by growing the bacteria for 4 days and colony quantiﬁcation.
Statistical analysis. All experiments were done at least three times with similar
results. All in vitro and human data were evaluated via one-way ANOVA followed
by Tukey’s test or via two-way ANOVA and Bonferroni’s multiple comparison test
with GraphPad Prism statistical software (version 8.0). Signiﬁcant difference was
deﬁned by *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 and ****p ≤ 0.0001.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The microarray data have been deposited in the Gene Expression Omnibus (GEO)
database with accession code GSE123623. Other data generated and analyzed during this
study are included in this published article and its Supplementary Information ﬁles. The
source data underlying Figs. 1, 2a, b, 3b-d, 4e-p and Supplementary Figs. 1–6, 12, 13, 16
and 19 are provided as a Source Data ﬁle.
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